Rigel Pharmaceuticals (RIGL) EBT Margin Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn | 7,318.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,318.00 |
| Dec 31, 2025 | 2,981.00 |
| Sep 30, 2025 | 12,471.00 |
| Jun 30, 2025 | 10,423.00 |
| Mar 31, 2025 | 18,558.00 |
| Dec 31, 2024 | 13,766.00 |
| Sep 30, 2024 | 12,035.00 |
| Jun 30, 2024 | 5,352.00 |
| Mar 31, 2024 | -7,886.00 |
| Dec 31, 2023 | 10,430.00 |
| Sep 30, 2023 | 5,685.00 |
| Jun 30, 2023 | 8,516.00 |
| Mar 31, 2023 | -9,146.00 |
| Dec 31, 2022 | 17,277.00 |
| Sep 30, 2022 | 13,060.00 |
| Jun 30, 2022 | 24,963.00 |
| Mar 31, 2022 | 2,647.00 |
| Dec 31, 2021 | 64,642.00 |
| Sep 30, 2021 | 39,062.00 |
| Jun 30, 2021 | 137,385.00 |